Embleema

Embleema

Created using Figma
Created using Figma

Letztes Update

31.10.2018

Ihre Krankengeschichte ist manipulationssicher und dank der Datensicherungs- und Verteilungsfunktionen von Blockchain stets verfügbar Sie wählen aus, welche Anbieter sehen können, welcher Teil Ihrer Krankengeschichte ist und Sie wissen genau, wer wann auf sie zugegriffen hat Ihre Privatsphäre ist vollständig geschützt in HIPAA-konformer Weise
Risiko: Sehr hoch
Private Sale
Okt, 2018
Mär, 2019
100% abgeschlossen
Geleistete Mittel - keine Daten
309
Ziel 20 000 000.00 USD
Limit 2 000 000.00 USD
Harte Kappe 30 000 000.00 USD
past
  • 1 RWD
    =
    0.2 USD
Token-Details
Ticker
RWD
Akzeptierte Währungen
ETH, BTC, BCH, FIAT
Firmendetails
Registrierter Firmenname
Embleema Inc
Eingetragenes Land
United States, France
Firma gegründet
Jun 1, 2017
Weitere Details
MVP / Prototyp
Ja
Plattform
Ethereum
KYC
Ja
Kategorien
Gesundheit

Über Embleema

Wir glauben, dass die Blockchain-Technologie der ideale Standard ist, der Patienten, Angehörigen der Gesundheitsberufe, Krankenkassen und Leistungserbringern eine gemeinsame, umfassende, langfristige und vertrauenswürdige Sicht auf die Krankengeschichte eines Patienten bieten kann. Wenn sie als Hauptbuch der Transaktionen erhalten bleibt, ist die Krankengeschichte eines Patienten für alle Beteiligten mit der entsprechenden Genehmigung des Patienten klar zugänglich und die beste Behandlungsoption kann bestimmt werden.

PatientTruth & Handel; ist eine Cloud- und Blockchain-basierte Softwarelösung, die in den verschiedenen Gesundheitszentren wie Krankenhäusern, Hausarztpraxen, Rehabilitationszentren, Pflegeheimen und Notfallzentren mit den unterschiedlichen Krankenakten eines Patienten verbunden ist und diese zu einem konsistenten, umfassende und manipulationssichere Anamnese. PatientTruth & Handel; bietet eine ganzheitliche Sicht auf die Krankengeschichte eines Patienten über Anbieter und Pflegezentren.

Eigenschaften

Patients can:

• Register and sign-on through the Patient Dapp interface,

• Upload their health records in the Blockchain, • Visualize their patient record,

• Authorize the sharing of their identified patient record to providers,

• Expose and sell their health records in the Marketplace against RWE tokens,

• Visualize a full audit-trail on their patient record access and health records sold,

• Visualize a statement of his/her RWE transactions.

 

Providers can:

• Register and sign-on through the Provider Dapp interface,

• Visualize an identified patient record, with due consent from the patient,

• Perform a health record quality check, when requested by the health record data owner,

• Visualize a statement of his/her RWE transactions,

 

Care Centers and other Data Owners can:

• Register and sign-on through the Data Owner Dapp interface,

• Have their health records indexed into the Blockchain and linked to patients,

• Expose and sell their health records in the Marketplace against RWE tokens, with due consent from the patients,

• Visualize a statement of RWE transactions,

 

Pharma companies, Payers and other Data Buyers can:

• Register and sign-on through the Data Buyer Dapp interface,

• Expose their inclusion criteria for health record purchases,

• Browse a list of data owners which own health records matching their inclusion criteria,

• Select the data owners they wish to purchase health records from,

• Execute the purchase in RWE tokens with data owners,

• Visualize a statement of RWE transactions,

 

Pharma companies and authorities can:

• Register and sign-on through the Real-World Evidence Dapp interface,

• Pharma companies register health products on which they wish to share with authorities Real-World Evidence, and define the patient records they wish to share,

• Authorities can visualize the shared Real-World Evidence from Pharma companies.

We expect Version 2 to be HIPAA compliant (see “Embleema and Privacy Compliance section” below) for the U.S. users and GDPR compliant for the European users. Version 2 will include health records from U.S. patients. Version 2 is planned to launch in Q3 2019.

Technische Information

Die Embleema Health Blockchain Version 2 enthält die folgenden Funktionen:


& bull; Gesundheitspezifische Smart Contracts zur Verwaltung der Patienteneinwilligung, Speicherung von Gesundheitsakten, Speicherung und Weitergabe von Patientendaten (identifiziert und nicht identifiziert), Zugangsprotokoll für Patientendatensätze und der
Marktplatz,
& bull; Eingebauter RWE-Token, der von der Blockchain für Transaktionsgebühren und andere Belohnungen generiert wird. Für RWE-Token-Transaktionen ist keine Gebührenzahlungsgebühr vom Absender erforderlich, und es ist eine vorhersehbare Abbauzeit vorhanden.
& bull; APIs und Health Record Parser zur Integration verschiedener Datenformateingaben für Health Records in die Blockchain
wie HL 7 FHIR,
CCD, proprietäre verbundene Geräteformate und andere Health Record-Formate,
& bull; Skalierbarkeit: bis zu 2 Millionen Patienten für den US-Markt,
& bull; Leistung: Die Visualisierung von Gesundheitsakten sollte unter
2 Sekunden erfolgen, das Mining in der Blockchain sollte unter 5 Sekunden erfolgen.
Der Abgleich von Datenkäufern mit den Dateneigner-Einschlusskriterien
im Marketplace sollte unter 1 Minute erfolgen Andere Batch-Verarbeitung wie das Analysieren und Indexieren von Datenquellen wird hinsichtlich der Leistung für jede Datenquelle bewertet.

Smart-Vertrag, der den Netzwerkteilnehmern ausgesetzt ist:
& bull; Gesundheitsakte: Schreiben, Lesen einer Gesundheitsakte in der Blockchain,
& bull; Patientenakte: Verbinden Sie Gesundheitsdaten mit einem bestimmten Patienten, lesen Sie die Patientenakte aus der Blockchain,
& bull; Patienteneinwilligung: Definiert die Berechtigung des Patienten, seine
Gesundheitsdaten (identifiziert und nicht identifiziert) zu teilen,
& bull; Audit-Trail: Bietet Dateninhabern einen Audit-Trail zu den Zugriffen auf ihre Gesundheitsdaten,
& bull; Marktplatz: stellt Dateninhaberdatenstatistiken für Metadaten
nach entsprechender Genehmigung von Patienten bereit, ermöglicht Datenkäufern die Suche nach Gesundheitsdatensätzen für den Kauf, entspricht Datenkäufern & rsquo; Einschlusskriterien
mit Datensätzen von Dateneigentümern, führt Kauftransaktionen
zwischen Datenkäufern und Dateneigentümern durch,
& bull; RWE-Token-Smart-Vertrag: RWE-Token werden als Belohnung für
-Datenbesitzer für das Speichern von Gesundheitsakten in der Blockchain (erste 3 Jahre) ausgegeben

Embleema Roadmap

  • Embleema’s growth plan

  • Embleema has already launched the first patient Blockchain.

    Version 1 is publicly accessible at https://patienttruth.embleema.com
    and contains the following functionalities:
    • Upload HL7 Continuity of Care Documents (CCD) medical records
    into blockchain by patients (U.S. patients only),
    • Upload of Fitbit information into blockchain by patients,
    • Consolidation of CCDs (U.S. patients only) and Fitbit information
    into a Medical history stored securely on blockchain,
    • Authorization management from patients for the sharing of their
    Medical history with providers,
    • Visualization by providers of patients’ Medical histories after due
    authorization from patients,
    • Audit-trail for patients of Medical history accesses by providers,
    • Compensation to patients in EBL tokens for uploading CCDs
    (U.S. patients only) and Fitbit information, as well as referrals of
    new patients and providers.

    Version 1 will be used to pilot and prove in real-life the relevance of
    the 2 key concepts carried by the Embleema Health Blockchain:
    • Patients have control of their health records and may share and
    sell their data to pharma companies: this pilot will start in September
    2018 with cysticfibrosis.com, a U.S. based patient community in
    Cystic Fibrosis (announced on July 17, 2018: https://medcitynews.
    com/2018/07/embleema-emerges-from-stealth-mode-launchesblockchain-
    based-health-record-system/),
    • Pharma companies and regulators share the next generation of
    RWE: real-time, individual-patient level 360 view medical histories,
    with continuous monitoring of the same patient and his/her full
    and trusted consent: this pilot will start in January 2019 with
    a top-5 global pharma company and a leading health regulator
    (announcement planned in Q4 2018).
  • End of 2019

  • End of 2019, Embleema expects to expand its Blockchain to the French
    market and the China marketplace with its 800 million connected patient
    population by striking a set of strategic distribution partnerships with major
    local players in the healthcare and technology industry.
  • Q3 2019

  • Concurrently to its V2 launch in Q3 2019, Embleema plans to set up consulting
    services for pharmaceuticals and health network to facilitate the
    adoption of blockchain in their processes and systems.
  • 2021

  • In 2021, Embleema plans to launch V3 of its Health Blockchain Network
    which will able to integrate mining nodes from pharma companies, payers
    and care centers. V3 will also implement an API allowing third party patient
    app providers to connect to the Blockchain and offer personalized services
    to patients through the Blockchain.
  • Weiterlesen
  • 2022

  • For 2022, with a critical mass of patient records stored onto the Blockchain,
    Embleema plans to offer advanced analytics services for various purposes:
    population health, observational studies, safety studies. Embleema will also
    start researching the possibility of offering predictive medicine services
    based on the wealth of data stored in the Blockchain.

Aktivität

Aktivität:
36
VERY LOW
Beiträge:
12
VERY LOW
Ansichten:
450
VERY LOW
Aktivität:
36
VERY LOW
Verdienen:
0
VERY LOW
Beiträge:
12
VERY LOW
Ansichten:
450
VERY LOW
Benutzer:
7
VERY LOW
Anhänger:
2 549
MEDIUM
Tweets:
487
HIGH
30 Tage Wachstum:
3

Embleema Mannschaft

Verifiziert 100%

Robert Chu
Founder, CEO and CTO
verifiziert
Prashant Khambekar,...
Chief Blockchain Development Executive
verifiziert
Pradeep Sreekanthan
Chief Delivery Officer
verifiziert
Vincent Galand
Manager, Operations
verifiziert
Pascal Becache
Business Development Executive
verifiziert
Nicolas Schmidt
Chief Product Officer
verifiziert
Alexis Normand
Head of Blockchain Consortium
verifiziert

Berater

Verifiziert 29%

Beachtung. Es besteht das Risiko, dass nicht verifizierte Mitglieder nicht Mitglieder des Teams sind

Vahan Simonyan, PhD
Advisor | Chief Scientist - WHISE-Embleema Health...
unbestätigt
Frederic Duchesne, P...
Advisor | CEO of Pierre Fabre Pharmaceuticals
unbestätigt
Atakan Seçkin
Advisor | User Experience
verifiziert
Pr. John Halamka, MD
Advisor | Professor of Innovation at Harvard Medic...
unbestätigt
Adel Al-Saleh
Advisor | CEO of T-Systems and Board Member of Deu...
unbestätigt
Bernard Gilly, PhD
Advisor | CEO at GenSight Biologics & Chairman at...
unbestätigt
Lorenzo Nardiello
Social Media Manager
verifiziert

Embleema Interviews

Atakan Seçkin
As a team member, сan you tell us about your role in the ICO project?
Branding, UI/UX design and implementation of PatientTruth (since POC to product launch) ICO dashboard and future projects
What do you think about idea?
I've designed several products in healthcare industry prior to this project, and none of those projects placed the patient in the center - information asymmetry is a real problem. I believe blockchain with thoughtful design can enable patients to do so much more with their data - not only in terms of being aware, but also the control to choose who can see your data, and monetize it on your own terms and no one else's. We know we have a long road ahead, but I have confidence that we have the best team in the world to be making this product, and we can evolve it in a way that will disrupt existing industries.
Lorenzo Nardiello
As a team member, сan you tell us about your role in the ICO project?
I am in charge of the social media : Telegram, Bitcointalk, Reddit, Discord ... I also organize the bounty program that will come soon and manage our ambassador.
What do you think about idea?
Imagine a world in which you can contribute to medical research and create safer, less expensive and faster new treatments against cancer and rares diseases. Imagine a tamper-proof, holistic, longitudinal and patient-centric worldwide health record interfacing with medical researchers, health regulators, physicians, care centers and the pharmaceutical industry.
Robert Chu
As a team member, сan you tell us about your role in the ICO project?
Founder and CEO of Embleema
I am responsible for overall product strategy, go-to-market and sales of our Embleema Health Blockchain which was launched publicly in July 2018
What do you think about idea?
Embleema Health Blockchain helps patients to advance clinical research by securely sharing their data to pharmaceutical companies during real-world evidence and clinical trial studies. Pharmaceutical companies benefit from faster and more precise data which they can in turn share with regulators such as the U.S. Food and Drug Administration (FDA). Ultimately, patients receive innovative treatments sooner, this is the meaning of our work.
Prashant Khambekar, PhD
As a team member, сan you tell us about your role in the ICO project?
I handle the blockchain development. This includes the ICO/token part.

I also help determine the strategy of the company and its products.
What do you think about idea?
It is a wonderful idea whose time has come. Patients should have the right to control their own health data. The token mechanism helps maintain third-party oversight into the Embleema products.
Pradeep Sreekanthan
As a team member, сan you tell us about your role in the ICO project?
Delivering different versions of the platform. Making the customer experience delightful and easy. Working with various teams.
What do you think about idea?
Revolutionary - bringing healthcare to the blockchain is unusual and will be quite disruptive. RWE in particular.
Vincent Galand
As a team member, сan you tell us about your role in the ICO project?
I am Ops Manager at Embleema Inc. and run Embleema’s ICO operations, coordinating the team of technical experts, legal advisors, social media marketing manager and contractors around the project. I am also developping the business in Europe with pharma companies.
What do you think about idea?
I believe blockchain’s decentralisation power will disrupt the healthcare industry allowing everyone to participate to the advancement of medical progresses. Moreover, we developped a real, concrete industrial use case of Blockchain technology to accelerate medical research, e.g. Real World Evidence / Phase IV clinical trials. We are the only ICO project with a product already available on the market (PatientTruth), first major clients (Pierre Fabre, Servier, others coming soon) and a full support from the medical research community, the pharmaceutical industry and patient associations.
Pascal Becache
As a team member, сan you tell us about your role in the ICO project?
In France and Europe : Investors relations, business development, relations with Pharma companies. As a former IBM and IMS Health executive, I unveil the value of the patient data blockchain for investors, pharmaceutical companies, public and private health insurances and regulators.
What do you think about idea?
Embleema is the future of medical, drugs and population health studies. It will disintermediate collection and use of health data, allowing more, faster, cheaper and more ethical and transparent research benefiting to patients and healthcare systems. It complies with all regulatory aspects in the countries they enter.
Nicolas Schmidt
As a team member, сan you tell us about your role in the ICO project?
I'm Chief Product Officer at Embleema: I lead of our next product development, translate users and customers' needs into a world-class product and manage our marketing.
What do you think about idea?
We're the only healthcare project with a blockchain solution in production, valuable data on usage, several pharma companies as customers and a team of world-class advisors. We achieved all of this before launching our ICO in order to reduce risks for potential subscribers.
Alexis Normand
As a team member, сan you tell us about your role in the ICO project?
I bring together patient advocacy groups & life sciences researchers and regulatoirs to create a decentralized marketplace for health data, to replace the slow, manual and costly process of collecting real world evidence (RWE) for late stage clinical research
What do you think about idea?
Allowing patients to opt-in to pharma research along their own terms is game changing. Only blockchain allows patients to assemble the full picture of their health data, own and share it, and be compensated for their active involvement in clinical research.

Embleema Letzte Nachrichten

1.48
negative
5.0 9
ICO Profil Vision Aktivität Potenzial Produkt Mannschaft
  • Da bei der Aktualisierung von Informationen zeitliche Unterschiede auftreten können, sollten genaue Informationen zu jedem ICO-Projekt über die offizielle Website oder andere Kommunikationskanäle überprüft werden.
  • Diese Informationen sind kein Vorschlag oder Ratschlag für Investitionen in die ICO-Finanzierung. Bitte recherchieren Sie die relevanten Informationen gründlich und entscheiden Sie sich für die Teilnahme von ICO.
  • Wenn Sie der Meinung sind, dass Probleme oder Probleme bei diesem Inhalt behoben werden müssen, oder wenn Sie Ihr eigenes ICO-Projekt zur Aufnahme einreichen möchten, senden Sie uns bitte eine E-Mail.
Bitte lesen Sie den Haftungsausschluss und die Risikowarnung. Zeige Disclaimer und Risikowarnung.
Planning an ICO? We can help with a wide range of support for all stages of your ICO